Frontiers in Cellular and Infection Microbiology

Scope & Guideline

Unlocking the secrets of immunity and infectious diseases.

Introduction

Explore the comprehensive scope of Frontiers in Cellular and Infection Microbiology through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Frontiers in Cellular and Infection Microbiology in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN2235-2988
PublisherFRONTIERS MEDIA SA
Support Open AccessYes
CountrySwitzerland
TypeJournal
Convergefrom 2011 to 2024
AbbreviationFRONT CELL INFECT MI / Front. Cell. Infect. Microbiol.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressAVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE CH-1015, SWITZERLAND

Aims and Scopes

The journal 'Frontiers in Cellular and Infection Microbiology' focuses on advancing knowledge in the areas of infectious diseases and microbial interactions with host cells. It encompasses a wide array of research themes, methodologies, and perspectives that contribute to understanding cellular microbiology, pathogen biology, and the implications for treatment and prevention of infections.
  1. Infection Biology and Pathogenesis:
    Research on the mechanisms of infection by various pathogens, including bacteria, viruses, fungi, and parasites. Studies often focus on understanding how these microorganisms exploit host cellular processes to establish infections.
  2. Host-Microbe Interactions:
    Investigations into how the host immune system interacts with pathogens and commensal organisms, including the role of the gut microbiome in health and disease.
  3. Antimicrobial Resistance and Novel Therapeutics:
    Research aimed at understanding the mechanisms of antimicrobial resistance and the development of new therapeutic strategies, including the use of phage therapy, probiotics, and novel drug compounds.
  4. Microbial Genomics and Metagenomics:
    Utilization of advanced genomic techniques to analyze microbial communities, pathogen genomes, and their implications for disease diagnosis and treatment.
  5. Clinical Microbiology and Diagnostics:
    Application of innovative diagnostic tools, including metagenomic next-generation sequencing, to improve pathogen detection and patient outcomes in infectious diseases.
  6. Translational Research:
    Focus on bridging laboratory research with clinical applications, including the development of vaccines and therapeutic interventions based on microbiome research.
The journal has seen significant growth in specific research areas that reflect current global health challenges and scientific advancements. These emerging themes are critical for understanding contemporary issues in microbiology and infectious diseases.
  1. Gut Microbiota and Health:
    Research focusing on the gut microbiome and its implications for various diseases, including metabolic disorders, autoimmune diseases, and infections, has surged. This reflects a growing recognition of the microbiome's role in overall health.
  2. COVID-19 Research:
    There has been an explosive increase in studies related to SARS-CoV-2, encompassing various aspects such as pathogenesis, immune response, diagnostics, and long-term effects, as the pandemic continues to influence global health.
  3. Antimicrobial Resistance Mechanisms:
    A growing body of research is dedicated to elucidating the mechanisms behind antimicrobial resistance, including the genetic and phenotypic characteristics of resistant strains, which is crucial for developing new treatment strategies.
  4. Phage Therapy and Novel Antimicrobials:
    Interest in bacteriophage therapy and other novel antimicrobial agents has increased as potential alternatives to traditional antibiotics, particularly in the context of rising antimicrobial resistance.
  5. Infection Control and Prevention Strategies:
    Studies focusing on innovative infection control measures, including the use of probiotics, dietary interventions, and environmental factors affecting microbial infection rates, are trending.

Declining or Waning

While the journal covers a broad range of topics, some areas have seen a decline in prominence over recent years. This may reflect shifting research priorities or advancements in specific methodologies that have changed the focus of the research community.
  1. Traditional Culture-Based Microbiology:
    There has been a noticeable decline in publications focusing solely on traditional culture-based methods for microbial identification and susceptibility testing, as newer techniques such as metagenomics gain prominence.
  2. Basic Virology Studies:
    Research papers dedicated to basic virology without a clear link to clinical implications or translational applications have become less frequent, as the focus shifts towards understanding viral pathogenesis and therapeutic strategies.
  3. Historical Epidemiological Studies:
    There appears to be a reduction in the publication of historical epidemiological studies that do not incorporate modern analytical techniques or tools, as more researchers seek to apply contemporary methods to solve current health issues.
  4. Studies on Non-Pathogenic Microbes:
    The exploration of non-pathogenic microbes and their roles in human health has decreased, with more emphasis placed on pathogenic microbes and their interactions with the immune system.

Similar Journals

Gut Pathogens

Unlocking Insights for Better Gut Health
Publisher: BMCISSN: 1757-4749Frequency: 1 issue/year

Gut Pathogens, published by BMC in the United Kingdom, is a premier open-access journal focusing on the intersection of gut health and infectious diseases. With its impact firmly established since its inception in 2009, the journal has earned impressive rankings, including Q1 in renowned categories such as Gastroenterology, Infectious Diseases, Microbiology, and Parasitology, while maintaining a strong presence in Virology. The journal serves as a vital resource for researchers, professionals, and students interested in the intricate relationships between gut microbiota and pathogenic organisms, offering insights that drive advancements in treatment and prevention strategies. By providing unrestricted access to high-quality research, Gut Pathogens fosters a collaborative environment, encouraging the dissemination of knowledge and innovation within the field. The journal publishes original research, reviews, and case studies, all designed to address contemporary challenges in gut health, ultimately aiming to improve patient outcomes and public health worldwide.

JOURNAL OF INFECTION

Transforming Understanding of Infectious Diseases
Publisher: W B SAUNDERS CO LTDISSN: 0163-4453Frequency: 12 issues/year

JOURNAL OF INFECTION is a premier academic publication in the fields of infectious diseases and medical microbiology, published by W B SAUNDERS CO LTD. With a profound impact factor and established since 1979, this journal serves as a crucial resource for researchers, clinicians, and policy-makers seeking to advance knowledge and understanding of infectious processes and their management. The JOURNAL OF INFECTION holds an impressive position in the academic hierarchy as reflected by its Q1 quartile rankings in both Infectious Diseases and Microbiology (medical) for 2023, further underscored by its Scopus rankings: #2 in Medical Microbiology and #5 in Medical Infectious Diseases, placing it in the 98th percentile overall. While the journal does not offer Open Access options, it provides a comprehensive outlet for innovative research, reviews, and clinical insights that drive the field forward. Published from the United Kingdom, it attracts a global readership keen on staying at the forefront of infectious disease research, making it an essential addition to any academic and clinical library.

CLINICAL MICROBIOLOGY AND INFECTION

Leading the Charge Against Infections
Publisher: ELSEVIER SCI LTDISSN: 1198-743XFrequency: 12 issues/year

CLINICAL MICROBIOLOGY AND INFECTION is a leading journal published by Elsevier Science Ltd, dedicated to advancing the field of infectious diseases and clinical microbiology. With its ISSN 1198-743X and E-ISSN 1469-0691, this esteemed journal has maintained its influential presence since 1995, showcasing high-impact research that addresses critical issues in the diagnosis, treatment, and prevention of infections. Ranked in the Q1 quartile for Infectious Diseases, Medicine (miscellaneous), and Microbiology (medical) categories, and boasting impressive Scopus rankings of #12 and #7 respectively, it sits at the forefront of scientific inquiry in these disciplines. Although it is not an Open Access journal, it provides comprehensive access options for institutions and individuals, ensuring the dissemination of vital research findings. As the field of clinical microbiology continues to evolve, CLINICAL MICROBIOLOGY AND INFECTION remains an essential resource for researchers, clinicians, and students aiming to stay informed on the latest developments and breakthroughs in understanding infectious diseases.

MIKROBIYOLOJI BULTENI

Unveiling the Complexities of Microbial Life
Publisher: ANKARA MICROBIOLOGY SOCISSN: 0374-9096Frequency: 4 issues/year

MIKROBIYOLOJI BULTENI, with ISSN 0374-9096, is a prestigious academic journal published by the ANKARA MICROBIOLOGY SOC, located in Ankara, Turkey. Established in 1973, this journal has been a vital conduit for disseminating research in the fields of Immunology, Microbiology, and Infectious Diseases, garnering a reputation as a significant contributor to the scientific community. The journal is currently ranked in the Q3 category within Immunology and Microbiology (miscellaneous), and Infectious Diseases, indicating its impactful presence amidst contemporary research. With access options that may be restricted, MIKROBIYOLOJI BULTENI actively welcomes submissions that advance the understanding of critical microbiological principles and practices, thereby supporting both national and international research efforts. Researchers, professionals, and students are encouraged to explore the latest findings shared in this journal, as it continually shapes the landscape of microbiology and infectious disease studies through its comprehensive and rigorous peer-reviewed publications.

Microbiology Spectrum

Illuminating the intricate world of microorganisms.
Publisher: AMER SOC MICROBIOLOGYISSN: 2165-0497Frequency: 6 issues/year

Microbiology Spectrum is a prominent peer-reviewed journal published by the American Society for Microbiology, dedicated to advancing the field of microbiology through the dissemination of high-quality research. Since its inception in 2013 and continuing until 2024, the journal has established a strong presence in key domains such as microbiology, immunology, cell biology, and ecology, achieving impressive quartile rankings including Q1 in Infectious Diseases and Q1 in Immunology and Microbiology as of 2023. With an emphasis on open access to its scholarly content, Microbiology Spectrum aims to foster collaboration and knowledge sharing among researchers, professionals, and students alike. The journal's scope encompasses a diverse range of topics pertinent to the field, making it an essential resource for anyone involved in microbiological research and its applications. Researchers looking to publish their findings in a respected journal will find Microbiology Spectrum's robust impact factor and Scopus rankings serve as testament to its significance and influence within the academic community.

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Connecting Science and Practice in Microbiology
Publisher: ELSEVIER SCIENCE INCISSN: 0732-8893Frequency: 12 issues/year

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, published by Elsevier Science Inc, is a leading journal in the fields of Infectious Diseases, Microbiology, and Medicine. Since its inception in 1983, this esteemed journal has consistently provided a platform for original research and comprehensive reviews that advance the understanding of diagnostic microbiology and its implications for infectious diseases. With an impressive impact factor placing it in the Q2 category in multiple relevant fields as of 2023, it stands out with Scopus rankings reinforcing its significance in academia, ranking #136 out of 344 in Infectious Diseases and #64 out of 140 in Medical Microbiology. This journal is essential for researchers, healthcare professionals, and students who seek to stay abreast of the latest developments and trends in infectious diagnostics. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE is committed to fostering excellence in research quality and academic rigor, ensuring accessibility to vital knowledge for addressing some of the most pressing health challenges of our time.

INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

Championing Open Access to Medical Microbiology Insights
Publisher: ELSEVIER GMBHISSN: 1438-4221Frequency: 8 issues/year

Welcome to the International Journal of Medical Microbiology, a leading publication in the field of microbiological research and infectious diseases, offered by Elsevier GmbH. Established in 2000, this esteemed journal provides a scholarly platform for the presentation of high-quality research, reviews, and innovations that bridge medical microbiology and clinical applications. With an impressive impact factor positioning it within the Q1 category across multiple disciplines, including Infectious Diseases, Microbiology, and Medicine, the journal is recognized for its rigorous peer-review process and significant contributions to advancing our understanding of microbial pathogenesis, diagnostics, and therapeutics. The International Journal of Medical Microbiology is committed to open access, promoting the dissemination of knowledge and accessibility for researchers, professionals, and students worldwide. Based in Munich, Germany, the journal continues to play a vital role in the global scientific community, fostering collaborations and inspiring future innovations in the fight against infectious diseases.

INFECTION AND IMMUNITY

Unveiling Innovations in Microbiology and Immunology
Publisher: AMER SOC MICROBIOLOGYISSN: 0019-9567Frequency: 12 issues/year

INFECTION AND IMMUNITY is a distinguished peer-reviewed journal published by the American Society for Microbiology, focusing on groundbreaking research in the fields of infection, immunology, microbiology, and parasitology. Established in 1971, this journal has built a robust legacy, converging years of scientific discovery with a vision towards 2024 and beyond. With an impressive Impact Factor, the journal holds significant rankings in various categories; its Q1 status in both Infectious Diseases and Parasitology underscores its high relevance and quality within the scientific community. Researchers and professionals alike will benefit from its content, as it promotes the latest advances in understanding immune responses and infectious agents, further legitimizing its place among the top quartiles of its respective fields. Access options are provided through traditional subscription models, ensuring a broad charitable dissemination of knowledge. As a pivotal resource for scholars and practitioners alike, INFECTION AND IMMUNITY stands at the forefront of microbiological and immunological research, fostering essential discourse that is crucial for advancing public health and scientific insight.

Indian Journal of Medical Microbiology

Pioneering Research in Medical Microbiology Since 1986
Publisher: ELSEVIERISSN: 0255-0857Frequency: 4 issues/year

Indian Journal of Medical Microbiology, published by Elsevier, is a pivotal peer-reviewed journal dedicated to the field of medical microbiology, providing a vital platform for research and scholarship since its inception in 1986. With an Open Access model established in 2001, it ensures the dissemination of scientific knowledge to a global audience, enhancing accessibility for researchers, professionals, and students alike. The journal's scope spans critical areas including immunology, infectious diseases, and microbiology, with an impressive trajectory marked by converged years of publication allowing for a comprehensive exploration of evolving scientific trends. As of 2023, the journal holds a Q3 ranking in Infectious Diseases and Microbiology (medical) and a Q4 ranking in Immunology and Microbiology categories, reflecting its significant yet growing impact in the field. Researchers seeking to contribute to or stay updated on the latest advancements in medical microbiology will find the Indian Journal of Medical Microbiology a valuable resource, as it consistently bridges the gap between emerging science and clinical application.

mSphere

Championing open access to revolutionary microbial research.
Publisher: AMER SOC MICROBIOLOGYISSN: Frequency: 6 issues/year

mSphere is a leading open-access journal published by the American Society for Microbiology, dedicated to the dynamic fields of Microbiology and Molecular Biology. Since its inception in 2016, mSphere has rapidly established itself as a reputable source of scholarly research, achieving notable impact factors and excellence within the academic community. The journal ranks in the top quartile (Q1) amongst its peers in Microbiology, and Q2 in the field of Molecular Biology, demonstrating its significance and relevance through Scopus rankings—specifically, it holds the #42 spot out of 182 in the Microbiology category and #108 out of 410 in Molecular Biology. With an editorial commitment to advancing the understanding of microbial and molecular sciences, mSphere provides an accessible platform for researchers, professionals, and students alike to disseminate groundbreaking findings. The journal promotes rigorous peer-review and invites innovative contributions aimed at enhancing microbial research mobility and molecular exploration. Accessible openly since 2016, mSphere continues to thrive as an influential publication driving scientific dialogue and discovery in the microbiological sciences.